RFK Jr. Panel Changes Baby Vaccine Rules

A CDC vaccine advisory panel, whose voting members were all appointed by Health and Human Services Secretary Robert F. Kennedy Jr., has voted 8–3 to end the long-standing policy of universal hepatitis B birth doses for babies of hepatitis-B-negative mothers. Despite acknowledging the move was “not based on data,” the panel recommends delaying the first shot until at least two months. This controversial reversal of a three-decade-old policy has sparked outcry from major medical groups, including the American Academy of Pediatrics, who warn the move will put infants at risk and introduce dangerous confusion for parents and clinicians.

Story Snapshot

CDC’s vaccine advisory panel voted 8–3 to end the universal hepatitis B birth dose for babies of hepatitis‑B‑negative mothers.
Advisers acknowledged the new push to delay the first shot until at least two months was not based on new outcome data.
The entire voting panel was appointed by HHS Secretary Robert F. Kennedy Jr., a long‑time vaccine critic.
Major medical groups, including the American Academy of Pediatrics, warn the move will put infants at risk.

CNN Confrontation Exposes a Troubling Shift at CDC

Viewers watching CNN saw something rare from the public health establishment: a vaccine adviser openly conceding the new recommendation to roll back the universal newborn hepatitis B shot was not driven by fresh data, but by the judgment of a newly reshaped CDC panel. The anchor’s visible shock captured what many Americans feel after years of mixed messages—how can unelected advisers tinker with long‑standing protections for newborns without bringing new evidence to the table?

The exchange came after the Advisory Committee on Immunization Practices, the CDC’s vaccine schedule gatekeeper, voted eight to three to stop recommending the hepatitis B birth dose for infants whose mothers test negative. Instead of a clear standard, the panel now urges “individual decision‑making” with clinicians and recommends delaying the first dose until at least two months after vaccination when parents choose vaccination. That change effectively removes a safety net that helped slash pediatric infections over the last three decades.

CNN Anchor Stunned as CDC Vaccine Advisor Warns Newborn Jabs Rollback 'Wasn't Based on Data' https://t.co/l7Mpaoe6UV

— Mediaite (@Mediaite) December 8, 2025

How a 30-Year-Old Newborn Protection Was Suddenly Reversed

Since 1991, American newborns have been offered a hepatitis B shot within 24 hours of birth, a policy credited with cutting infections in infants and children by roughly 99 percent. That universal approach recognized real‑world problems: some mothers are never tested, some are tested too late, and some infections slip past screening. Babies can also be exposed by infected household members. The birth dose was a simple, low‑cost way to close those gaps and quietly protect millions of families.

Despite that track record, the new ACIP majority decided the universal birth dose is no longer necessary for babies of hepatitis‑B‑negative mothers and that the first shot should not be given before two months in those cases. During the meeting, members and observers admitted there were no new safety or effectiveness concerns driving the change and no fresh data justifying a hard ban on early dosing. Instead, they leaned on a reinterpreted risk‑benefit judgment, a move critics say turns scientific policy into an ideological tug‑of‑war.

Kennedy’s Hand‑Picked Panel and the Politicizing of Public Health

The controversy deepens when you look at who now controls the CDC’s vaccine advice. Every voting member involved in this decision was appointed by Health and Human Services Secretary Robert F. Kennedy Jr., a long‑time vaccine opponent who built his brand attacking mainstream immunization programs. Major pediatric and public health groups say the committee has been stacked with skeptics, including non‑physicians, who came in openly vowing to “upend” the childhood schedule starting with hepatitis B.

Prominent vaccine experts such as Paul Offit and Peter Hotez refused invitations to participate, warning that lending their names would “legitimize” a process they considered rigged toward a predetermined outcome. The American Academy of Pediatrics has been boycotting meetings since Kennedy removed the prior panel, yet still insists doctors continue giving the birth dose. When even establishment medical organizations balk at a CDC advisory process, it signals a deeper breakdown in how health agencies are supposed to guard the public interest.

Parents Caught Between Conflicting Authorities and Real‑World Risks

For everyday parents, the result is confusion. Federal advisers now say low‑risk infants can wait, while the AAP and some states, such as New York, say the birth dose remains essential. Hospitals, pediatricians, and state health departments may follow different playbooks, leaving families to sort out conflicting guidance during one of the most vulnerable moments of a child’s life. That fragmentation is exactly what many conservatives warned about when politicized bureaucracies overreached during COVID and lost the public’s confidence.

Medical critics of the rollback stress that delaying vaccination widens the window when infants can silently contract an incurable liver virus that may not cause obvious illness for years. More babies will leave the hospital unprotected, and some will never complete the series because of spotty follow‑up or chaotic family situations. Those most at risk often live in communities already struggling with access to care, meaning another seemingly technical tweak by Washington could land hardest on the least powerful.

What This Fight Reveals About Data, Power, and Trust

For a conservative audience that values limited government and honest, evidence‑based decision‑making, this episode raises hard questions. A politically reshaped advisory body just rolled back a successful, decades‑old newborn safeguard while admitting there is no new data to justify doing so.

Whether one supports aggressive vaccination schedules or prefers a more restrained approach, the core issue here is transparency and accountability. If a federal panel can scrap a policy that nearly eliminated a serious childhood infection without fresh evidence, what prevents future committees from rewriting other long‑standing medical norms the same way? As President Trump’s administration focuses on cleaning up bureaucratic excess and restoring constitutional balance, conservatives will be watching closely to see whether vaccine policy—and every other realm of public health—returns to the principle that data, not politics, must drive decisions about our children’s lives.

Watch the report: CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation